MK
Mark Andrew Killick

Publications (2)

HIV-1 bispecific antibody iMab-N6 exhibits enhanced breadth but not potency over its parental antibodies iMab and N6
Article scientifique · 2022
Engineering and characterising a novel, highly potent bispecific antibody iMab-CAP256 that targets HIV-1
Article scientifique · 2019

Domaines principaux

Sciences de la santé2

Statistiques

Consultations9
Téléchargements0